Literature DB >> 21642890

Binocular balance in normal vision and its modulation by mean luminance.

Peng Zhang1, William Bobier, Benjamin Thompson, Robert F Hess.   

Abstract

PURPOSE: To better understand the neural basis of sensory dominance in the normal population, we applied a recently established test designed to quantify the degree of suppression in amblyopia to participants with normal binocular vision.
METHODS: This test quantifies the degree of dichoptic imbalance in coherent motion sensitivity by manipulating the contrast of stimuli seen by the two eyes. The contrast at which balanced dichoptic motion sensitivity occurs is referred to as the "balance point" and is an estimate of the degree of suppression. We apply the same logic to the measurement of sensory dominance by measuring the distribution of "balance points" within the normal population.
RESULTS: We show that although most subjects are balanced or only weakly imbalanced, a minority is strongly imbalanced. To ascertain the site of sensory dominance, we assessed the degree to which normal sensory balance can be modulated by changing the interocular mean luminance. We found that mismatches in mean luminance between the two eyes had a pronounced effect on the balance point determination.
CONCLUSIONS: Because cells in the lateral geniculate nucleus exhibit a strong modulation to sustained changes in the mean light level, this may suggests that the inhibitory circuits underlying sensory eye dominance are located at a precortical site.

Entities:  

Mesh:

Year:  2011        PMID: 21642890     DOI: 10.1097/OPX.0b013e3182217295

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  11 in total

1.  Rebalancing binocular vision in amblyopia.

Authors:  Jian Ding; Dennis M Levi
Journal:  Ophthalmic Physiol Opt       Date:  2014-01-12       Impact factor: 3.117

2.  The measurement and treatment of suppression in amblyopia.

Authors:  Joanna M Black; Robert F Hess; Jeremy R Cooperstock; Long To; Benjamin Thompson
Journal:  J Vis Exp       Date:  2012-12-14       Impact factor: 1.355

3.  Dynamics of normalization underlying masking in human visual cortex.

Authors:  Jeffrey J Tsai; Alex R Wade; Anthony M Norcia
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

4.  Small-aperture monovision and the Pulfrich experience: absence of neural adaptation effects.

Authors:  Sotiris Plainis; Dionysia Petratou; Trisevgeni Giannakopoulou; Hema Radhakrishnan; Ioannis G Pallikaris; W Neil Charman
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

5.  Mechanisms of recovery of visual function in adult amblyopia through a tailored action video game.

Authors:  Indu Vedamurthy; Mor Nahum; Daphne Bavelier; Dennis M Levi
Journal:  Sci Rep       Date:  2015-02-26       Impact factor: 4.379

6.  Suprathreshold Motion Perception in Anisometropic Amblyopia: Interocular Speed Matching and the Pulfrich Effect.

Authors:  Goro Maehara; Syunsuke Araki; Tsuyoshi Yoneda; Benjamin Thompson; Atsushi Miki
Journal:  Optom Vis Sci       Date:  2019-06       Impact factor: 1.973

7.  The effect of unilateral mean luminance on binocular combination in normal and amblyopic vision.

Authors:  Jiawei Zhou; Wuli Jia; Chang-Bing Huang; Robert F Hess
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Monocular perceptual learning of contrast detection facilitates binocular combination in adults with anisometropic amblyopia.

Authors:  Zidong Chen; Jinrong Li; Jing Liu; Xiaoxiao Cai; Junpeng Yuan; Daming Deng; Minbin Yu
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

9.  Interocular ND filter suppression: Eccentricity and luminance polarity effects.

Authors:  Akash S Chima; Monika A Formankiewicz; Sarah J Waugh
Journal:  J Vis       Date:  2020-07-01       Impact factor: 2.240

10.  Reduced fixation stability induced by peripheral viewing does not contribute to crowding.

Authors:  Rajkumar Nallour Raveendran; Arun Kumar Krishnan; Benjamin Thompson
Journal:  J Vis       Date:  2020-10-01       Impact factor: 2.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.